Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1CNS 1

Conditions

Lymphoma 128Lymphoma, Non-Hodgkin 98Precursor Cell Lymphoblastic Leukemia-Lymphoma 93Hodgkin Disease 78Leukemia, Myeloid, Acute 74Myelodysplastic Syndromes 69Lymphoma, Large B-Cell, Diffuse 66Leukemia, Lymphocytic, Chronic, B-Cell 65Leukemia 63Lymphoma, Mantle-Cell 59Lymphoma, Follicular 57Burkitt Lymphoma 44Multiple Myeloma 40Lymphoma, Large-Cell, Immunoblastic 40Lymphoma, B-Cell, Marginal Zone 37Myeloproliferative Disorders 29Recurrence 28Leukemia, Myelogenous, Chronic, BCR-ABL Positive 25Neoplasms, Plasma Cell 24Leukemia, Myeloid, Accelerated Phase 24Leukemia, Myeloid, Chronic-Phase 23Congenital Abnormalities 22Leukemia, Myelomonocytic, Chronic 21Dendritic Cell Sarcoma, Interdigitating 21Waldenstrom Macroglobulinemia 20Graft vs Host Disease 20Primary Myelofibrosis 18Blast Crisis 17Lymphoma, T-Cell, Cutaneous 16Leukemia, Myelomonocytic, Juvenile 16

Interventions

entinostat 2trametinib 1sonidegib 1ribociclib 1carboxyamido-triazole 1Thalidomide 1Temozolomide 1Psychiatric Rehabilitation 1Paclitaxel 1Melphalan 1Granulocyte Colony-Stimulating Factor 1Gemcitabine 1Filgrastim 1Fentanyl 1Docetaxel 1Bortezomib 1Amplified Fragment Length Polymorphism Analysis 190Y-octreotide, DOTA-Tyr(3)- 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pinealoma × Melphalan × Lymphoid × Clear all
NCT00253721 2017-04-21

Melphalan With BBBD in Treating Patients With Brain Malignancies

OHSU Knight Cancer Institute

Phase 1 Terminated
21 enrolled
CNSLymphoid

Astrocytoma, Brain Neoplasms, Glioma, Lymphoma, Medulloblastoma, Neoplasm Metastasis, Oligodendroglioma, Pinealoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡